| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Member of 10% Owner Group | Member of 10% Owner Group
1 company
Cardinal Equity Fund, L.P. is Member of 10% Owner Group at GRDN.
Historically, Cardinal Equity Fund, L.P.'s trades have earned a below-average insider score of 14/100 across 3 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -78.7%.
The GRDN filings lean toward selling, a net 596,991 shares.
Cardinal Equity Fund, L.P. has 4 Form 4 filings on record from March 2025 to September 2026, all as Member of 10% Owner Group at Guardian Pharmacy Services (GRDN), 2025–2026.
The 6 reported transactions were 3 option exercises and 3 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $14.7M.
The largest open-market sale was 275,728 shares of GRDN at an average $29.68 on March 20, 2026, about $8.2M.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.